Survival benefit of early infant antiretroviral therapy is compromised when diagnosis is delayed.
View/ Open
Date
2012-07Author
Wamalwa, D
Benki-Nugent, S
Langat, A
Tapia, K
Ngugi, Elizabeth N
Slyker, JA
Richardson, BA
John-Stewart, GC
Type
ArticleLanguage
enMetadata
Show full item recordAbstract
Late presentation is common among African HIV-1-infected infants. Incidence and correlates of mortality were examined in 99 infants with HIV-1 diagnosis by 5 months of age. Twelve-month survival was 66.8% (95% confidence interval: 55.9-75.6%). World Health Organization stage 3 or 4, underweight, wasting, microcephaly, low hemoglobin, pneumonia and gastroenteritis predicted mortality. Early HIV-1 diagnosis with antiretroviral therapy before symptomatic disease is critical for infant survival.
URI
http://www.ncbi.nlm.nih.gov/pubmed/22544051http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/45047
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756892/
Citation
Pediatr Infect Dis J. 2012 Jul;31(7):729-31. doi: 10.1097/INF.0b013e3182587796Publisher
University of Nairobi Department of Paediatrics
Collections
- Faculty of Health Sciences (FHS) [10377]